News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,483 Results
Type
Article (33344)
Company Profile (640)
Press Release (610499)
Section
Business (196860)
Career Advice (2097)
Deals (36162)
Drug Delivery (100)
Drug Development (77438)
Employer Resources (161)
FDA (15383)
Job Trends (14666)
News (331849)
Policy (28808)
Tag
Academia (1330)
Alliances (46687)
Alzheimer's disease (1231)
Approvals (15353)
Artificial intelligence (190)
Bankruptcy (371)
Best Places to Work (10903)
Biotechnology (437)
Breast cancer (197)
Cancer (1560)
Cardiovascular disease (122)
Career advice (1726)
Cell therapy (351)
Clinical research (62868)
Collaboration (663)
Compensation (368)
COVID-19 (2154)
C-suite (172)
Data (1558)
Diabetes (197)
Diagnostics (6222)
Earnings (81867)
Employer resources (139)
Events (107922)
Executive appointments (577)
FDA (16230)
Funding (588)
Gene therapy (240)
GLP-1 (655)
Government (2861)
Healthcare (16149)
Infectious disease (2258)
Inflammatory bowel disease (118)
Interviews (422)
IPO (17149)
Job creations (4218)
Job search strategy (1434)
Layoffs (506)
Legal (7180)
Lung cancer (231)
Manufacturing (249)
Medical device (13575)
Medtech (13580)
Mergers & acquisitions (19387)
Metabolic disorders (534)
Neuroscience (1650)
NextGen: Class of 2025 (6002)
Non-profit (1927)
Northern California (2092)
Obesity (304)
Opinion (235)
Patents (163)
People (56325)
Pharmaceutical (132)
Phase I (19812)
Phase II (28122)
Phase III (20770)
Pipeline (717)
Postmarket research (1909)
Preclinical (7921)
Radiopharmaceuticals (254)
Rare diseases (316)
Real estate (5702)
Regulatory (20349)
Research institute (1326)
Resumes & cover letters (330)
Southern California (1763)
Startups (3873)
United States (18437)
Vaccines (576)
Weight loss (216)
Date
Last 7 days (587)
Last 30 days (2418)
Last 365 days (34639)
2025 (4427)
2024 (35570)
2023 (40341)
2022 (50585)
2021 (53789)
2020 (50825)
2019 (42057)
2018 (32149)
2017 (32537)
2016 (30799)
2015 (36161)
2014 (28911)
2013 (23925)
2012 (25503)
2011 (25642)
2010 (23515)
Location
Africa (662)
Arizona (151)
Asia (39717)
Australia (6508)
California (4840)
Canada (1701)
China (394)
Colorado (217)
Connecticut (236)
Europe (86625)
Florida (652)
Georgia (162)
Illinois (393)
Indiana (267)
Maryland (638)
Massachusetts (3765)
Michigan (211)
Minnesota (339)
New Jersey (1354)
New York (1341)
North Carolina (924)
Northern California (2092)
Ohio (158)
Pennsylvania (1070)
South America (1061)
Southern California (1763)
Texas (694)
Utah (144)
Washington State (485)
644,483 Results for "orthopaedic implant company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Zeda Announces Acquisition of The Orthopaedic Implant Company
Zeda, Inc. (Zeda), a global leader in innovative healthcare solutions, proudly announced today the acquisition of The Orthopaedic Implant Company (OIC), an orthopaedic implant company recognized as the leader in value-based implants.
February 13, 2024
·
2 min read
Pharm Country
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor, trauma, and revision surgery, announced that the U.S. Food & Drug Administration (FDA) granted the company a De Novo approval for its novel antibacterial coated implants.
April 8, 2024
·
4 min read
Genetown
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
Hyalex Orthopaedics today announced that patients have successfully received HYALEX Knee Implants as part of the company’s first-in-human clinical trials of its novel HYALEX Knee Cartilage System.
April 22, 2024
·
3 min read
Genetown
Miach Orthopaedics Raises $20 Million in Series B Extension
Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration Implant, announced closing of a $20 million Series B extension financing round.
April 2, 2024
·
4 min read
Press Releases
Aspen Medical Products Acquires Advanced Orthopaedics
January 30, 2025
·
2 min read
Press Releases
Glidewell Launches Glidewell(TM) Tooth Replacement Solution for Implant Treatment
February 21, 2025
·
3 min read
Genetown
Miach Orthopaedics Launches BEAR® Implant Registry Study
Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue restoration, announced initiation of the Bridge Registry Post-Market Study of the company’s Bridge-Enhanced ACL Restoration Implant for anterior cruciate ligament tears.
May 2, 2023
·
5 min read
Press Releases
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Onkos Surgical® to Accelerate Commercialization of Novel Antibacterial Implant Technology
January 8, 2025
·
4 min read
Press Releases
Daré Bioscience and Theramex Announce Co-Development and Licensing Agreement for a Potential Biodegradable Long-Acting Contraceptive Implant
February 21, 2025
·
10 min read
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies
Sensorion announces that promising new data and analysis results from the SENS-401 following cochlear implantation Phase 2a clinical study will be presented at the 17th International Conference on Cochlear Implants and Other Implantable Technologies taking place on July 10-13, 2024, in Vancouver, Canada.
June 20, 2024
·
5 min read
1 of 64,449
Next
